JDRF Blog

There are 31 item(s) tagged with the keyword "Research".

11. Canadian Post-doctoral Fellowships Awarded in type 1 diabetes Research

Lilly Canada provided JDRF with $220,000 in 2013-2014 in support of the creation of a national clinical training program to enable young investigators to further engage in medical research associated with type 1 diabetes.


12. Canada at the Forefront of Diabetes Research, Bringing Innovation from the Lab to the Bedside

JDRF Canadian Clinical Trial Network (JDRF CCTN) has announced the official launch of its expansion to western Canada through the generous support of the WB Family Foundation.


13. Cure

Type 1 diabetes (T1D) occurs when the body's own immune system misguidedly attacks and destroys certain cells in the pancreas, an organ about the size of a hand that is located behind the lower part of the stomach. These cells – called beta cells – are contained, along with other types o...


14. Prevent

The changing frequency of type 1 diabetes (T1D) across the world with its increasing public health burden and the recent impressive scientific advances have catalyzed a more urgent and focused approach to prevention. The incidence of type 1 diabetes has been increasing for the last three to four dec...


15. Immune Therapies Research

JDRF is actively supporting research to better understand the process leading to the misguided immune attack on the beta cells (the autoimmune attack) and potential therapeutic interventions at each stage of human type 1 diabetes (T1D). While there have been many recent advances in the use of genera...


16. Regeneration Research

In contrast to replacement of beta cells using outside sources of cells, which involves a surgical transplant procedure, internal regeneration of beta cells has the potential to restore beta cell function in large numbers of individuals using drug-based approaches. JDRF has prioritized funding of be...


17. Replacement Research

Replacement of functional beta cells by either whole pancreas or islet transplantation from another source has established proof of concept that restoration of functional beta cells along with immunosuppression therapy has the potential to restore insulin independence. This success, however, is hamp...


18. Diabetes Research Symposium

JDRF is the world-leader in funding innovative type 1 diabetes (T1D) research. We invite you to hear updates on JDRF-funded research and stories from inspirational T1D champions, as we continue on our promise to make type one type none.


19. Mission and Values

For over 40 years, JDRF has been a global leader in the search for an end to type 1 diabetes (T1D), through both research funding and advocacy. During that time, we have always talked about a cure as a singular destination: a return to normal physiology.


20. JDRF & Amylin Partner to Investigate Therapy to Improve Blood Glucose Control

NEW YORK and SAN DIEGO, Nov. 16, 2010 - The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the eff...


Lets turn type one into type none